US firm found mold long before shipping tainted drugs

October 27, 2012 by Mira Oberman

A pharmacy tied to a meningitis outbreak repeatedly found bacteria and mold in its facility long before shipping tainted drugs to patients, US officials said Friday as the death toll rose to 25.

The New England Compounding Center (NECC) voluntarily shut down operations and recalled all of its products in the wake of the unprecedented outbreak, which say has sickened 338 people in 18 states.

The fungus that contaminated the steroids and caused the potentially was so prevalent it could be seen with the naked eye.

Investigators searching a bin of 321 vials found "greenish black foreign matter" in 83 vials and "white filamentous material" in 17 others, according to a preliminary report by the .

The firm's own inspection reports also painted a dirty picture.

While internal tests found mold and bacteria on 29 occasions since January 3, there was "no investigation conducted by the firm when levels exceeded their action limits, and no identification of the isolates," the FDA report said.

The company also did not have any documentation of efforts to remove the contaminants.

"Manufacturers and compounding firms know what to do," Paul Teitell, of the FDA's office of regulatory affairs, said in a conference call.

"They have the responsibility to manufacture quality drugs and to have processes in place to make sure there's no breakdown in the supply or processes that would cause contamination."

Federal investigators found visibly dirty equipment and a failure to follow standard practices when they inspected the facility after tracing the outbreak to NECC's products earlier this month.

The pharmacy's staff told them that the air conditioning in the 'clean rooms' was turned off overnight, even though a consistent temperature is needed to prevent growth of bacteria and mold.

Inspectors also found pools of dirty water surrounding a leaking boiler just steps from the clean rooms and noted that the facility's air intake unit was within range of dust kicked up by a neighboring recycling company.

State officials formally revoked NECC's license on Wednesday after citing the firm for significant sanitary violations.

Massachusetts officials also noted that on at least 13 occasions NECC shipped the tainted drugs to customers before internal tests came back to determine if the vials of steroids—which are typically injected into the spine to treat back pain—were sterile.

The FDA said it is too early to discuss consequences, however criminal prosecutors are participating in the investigation.

The outbreak has led to calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.

Critics say drug manufacturers have found a way to sidestep costly and strict oversight by classifying themselves as pharmacies, which are given freer rein to mix drug compounds for patients.

Some 14,000 people in 23 states are at risk after receiving potentially tainted doses of the NECC steroids and the FDA has warned that patients receiving a host of other NECC products are also at risk.

Officials have said it could be weeks before authorities have a final tally of the infections, due to the disease's long incubation period.

Explore further: US firm loses license as tainted drug toll rises to 24

Related Stories

US firm loses license as tainted drug toll rises to 24

October 25, 2012
US officials revoked the license Wednesday of a Massachusetts pharmacy cited for significant sanitary violations as the toll from a meningitis outbreak tied to its tainted drugs rose to 24.

US meningitis death toll up to 23: CDC

October 20, 2012
The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.

Massachusetts: Fungus at meningitis-linked firm

October 23, 2012
(AP)—Massachusetts state officials investigating a pharmacy linked to a deadly outbreak of meningitis said Tuesday they found shoddy sterilization practices and unclean conditions there, including debris-covered floor mats ...

US meningitis outbreak death toll rises to 15

October 14, 2012
The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.

US tainted drug outbreak rises to 185 cases

October 12, 2012
The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

Long wait for answers in US tainted drug outbreak

October 13, 2012
Thousands of Americans who may have been injected with a tainted steroid will have to wait weeks to see if they have been infected with meningitis as investigators seek answers to a widening outbreak.

Recommended for you

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.